Henry Schein (NASDAQ:HSIC) Price Target Cut to $70.00 by Analysts at UBS Group

Key Points

• UBS Group has lowered its price target for Henry Schein from $75.00 to $70.00, while maintaining a "neutral" rating on the stock, suggesting a potential upside of 6.33% from its current price.
• Henry Schein's latest earnings report showed an EPS of $1.10, missing estimates by $0.09, although revenue grew by 3.3% year-over-year.
• Institutional investors own 96.62% of Henry Schein's stock, with notable increases in holdings from several major investment firms in the last quarter.

Henry Schein (NASDAQ:HSIC - Free Report) had its target price decreased by UBS Group from $75.00 to $70.00 in a research report sent to investors on Wednesday morning,Benzinga reports. UBS Group currently has a neutral rating on the stock.

Several other research analysts also recently commented on the stock. Leerink Partners set a $75.00 price target on shares of Henry Schein in a report on Monday, July 14th. Piper Sandler lowered their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Evercore ISI decreased their price target on shares of Henry Schein from $78.00 to $70.00 and set an "in-line" rating on the stock in a report on Wednesday. Finally, Stifel Nicolaus reaffirmed a "hold" rating and set a $75.00 price objective (down from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Nine research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, Henry Schein presently has a consensus rating of "Hold" and an average price target of $75.58.

Henry Schein Stock Performance

HSIC traded down $0.17 during trading on Wednesday, hitting $65.73. 306,482 shares of the company traded hands, compared to its average volume of 1,754,912. Henry Schein has a one year low of $60.56 and a one year high of $82.49. The stock's fifty day moving average is $71.15 and its 200 day moving average is $71.17. The company has a quick ratio of 0.75, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The firm has a market cap of $8.00 billion, a P/E ratio of 21.15, a price-to-earnings-growth ratio of 2.15 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business had revenue of $3.24 billion for the quarter, compared to analysts' expectations of $3.22 billion. During the same period last year, the company earned $1.23 earnings per share. Henry Schein's revenue for the quarter was up 3.3% compared to the same quarter last year. As a group, equities analysts predict that Henry Schein will post 4.74 EPS for the current fiscal year.

Institutional Investors Weigh In On Henry Schein

Several hedge funds have recently made changes to their positions in HSIC. Vanguard Personalized Indexing Management LLC lifted its holdings in shares of Henry Schein by 3.5% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 4,669 shares of the company's stock valued at $341,000 after purchasing an additional 157 shares during the last quarter. Equitable Trust Co. increased its position in Henry Schein by 3.1% during the 2nd quarter. Equitable Trust Co. now owns 5,317 shares of the company's stock valued at $388,000 after buying an additional 158 shares in the last quarter. Guggenheim Capital LLC raised its stake in Henry Schein by 2.5% during the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock valued at $445,000 after buying an additional 159 shares during the last quarter. TD Asset Management Inc boosted its holdings in Henry Schein by 0.8% in the second quarter. TD Asset Management Inc now owns 22,016 shares of the company's stock worth $1,608,000 after acquiring an additional 164 shares in the last quarter. Finally, Radnor Capital Management LLC grew its stake in shares of Henry Schein by 1.6% in the second quarter. Radnor Capital Management LLC now owns 11,415 shares of the company's stock worth $834,000 after acquiring an additional 180 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.